1
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Long-Range RNA Interaction of Two Sequence Elements Required for Endonucleolytic Cleavage of Human Insulin-Like Growth Factor II mRNAs

, , &
Pages 235-245 | Received 25 Jul 1994, Accepted 05 Oct 1994, Published online: 30 Mar 2023

REFERENCES

  • Abrahams, J. P., M. Van den Berg, E. Van Batenburg, and C. Pleij. 1990. Prediction of RNA secondary structure, including pseudoknotting, by computer simulation. Nucleic Acids Res. 18:3035–3044.
  • Bandyopadhay, R., M. Coutts, A. Krowczynska, and G. Brawerman. 1990. Nuclease activity associated with mammalian mRNA in its native state: basis for selectivity in mRNA decay. Mol. Cell. Biol. 10:2060–2069.
  • Binder, R., J. A. Horowitz, J. P. Basilion, D. M. Koeller, R. D. Klausner, and J. B. Harford. 1994. Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 39 UTR and does not involve poly(A) tail shortening. EMBO J. 13:1969–1980.
  • Binder, R., S. L. Hwang, R. Ratnasabapathy, and D. L. Williams. 1989. Degradation of apolipoprotein II mRNA occurs via endonucleolytic cleavage at 59-AAU-39/59-UAA-39 elements in single-stranded loop domains of the 39-noncoding region. J. Biol. Chem. 264:16910–16918.
  • Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1991. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 39 untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11:3288–3295.
  • Brewer, G., and J. Ross. 1988. Poly(A) shortening and degradation of the 39 A1U-rich sequences of human c-myc mRNA in a cell-free system. Mol. Cell. Biol. 8:1697–1708.
  • Brewer, G., and J. Ross. 1989. Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol. Cell. Biol. 9:1996–2006.
  • Brown, B. D., and R. M. Harland. 1990. Endonucleolytic cleavage of a maternal homeo box mRNA in Xenopus oocytes. Genes Dev. 4:1925–1935.
  • Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
  • Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
  • Daughaday, W. H., and P. Rotwein. 1989. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr. Rev. 10:68–91.
  • DeChiara, T. M., E. J. Robertson, and A. Efstratiadis. 1991. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849–859.
  • De Pagter-Holthuizen, P., M. Jansen, R. A. Van der Kammen, F. M. A. Van Schaik, and J. S. Sussenbach. 1988. Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. Biochim. Biophys. Acta 950:282–295.
  • Froesch, E. R., C. Schmidt, J. Schwander, and J. Zapf. 1985. Actions of insulin-like growth factors. Annu. Rev. Physiol. 47:443–467.
  • Graves, R. A., N. B. Pandey, N. Chodchoy, and W. F. Marzluff. 1987. Translation is required for regulation of histone mRNA degradation. Cell 48:615–626.
  • Holthuizen, P. E., C. B. J. M. Cleutjens, G. J. C. Veenstra, F. M. Van der Lee, A. M. C. B. Koonen-Reemst, and J. S. Sussenbach. 1993. Differential expression of the human, mouse and rat IGF- II genes. Regul. Pept. 48:77–89.
  • Klausner, R. D., T. A. Rouault, and J. B. Harford. 1993. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72:19–28.
  • Koeller, D. M., J. A. Horowitz, J. L. Casey, R. D. Klausner, and J. B. Harford. 1991. Translation and the stability of mRNAs encoding the trans-ferrin receptor and c-fos. Proc. Natl. Acad. Sci. USA 88:7778–7782.
  • Lim, S.-K., C. D. Sigmund, K. W. Gross, and L. E. Maquat. 1992. Nonsense codons in human β-globin mRNA result in the production of mRNA degradation products. Mol. Cell. Biol. 12:1149–1161.
  • Malter, J. S. 1989. Identification of an AUUUA-specific messenger RNA binding protein. Science 246:664–666.
  • Meinsma, D., P. E. Holthuizen, J. L. Van den Brande, and J. S. Sussenbach. 1991. Specific endonucleolytic cleavage of IGF-II mRNAs. Biochem. Bio-phys. Res. Commun. 179:1509–1516.
  • Meinsma, D., W. Scheper, P. E. Holthuizen, and J. S. Sussenbach. 1992. Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-II gene. Nucleic Acids Res. 20:5003–5009.
  • Mullner, E. W., B. Neupert, and L. C. Kuhn. 1989. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell 58:373–382.
  • Nielsen, F. C., and J. Christiansen. 1992. Endonucleolysis in the turnover of insulin-like growth factor II mRNA. J. Biol. Chem. 267:19404–19411.
  • Nielsen, F. C., G. Haselbacher, J. Christiansen, M. Lake, M. Gronborg, and S. Gammeltoft. 1993. Biosynthesis of 10 kDa and 7.5 kDa insulin-like growth factor II in a human rhabdomyosarcoma cell line. Mol. Cell. Endocrinol. 93:87–95.
  • Ogawa, O., M. R. Eccles, J. Szeto, L. A. McNoe, K. Yun, M. A. Maw, P. J. Smith, and A. E. Reeve. 1993. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms’ tumour. Nature (London) 362:749–751.
  • Ohlsson, R., L. Holmgren, A. Glaser, A. Szpecht, and S. Pfeifer-Ohlsson. 1989. Insulin-like growth factor II and short-range stimulatory loops in control of human placental growth. EMBO J. 8:1993–1999.
  • Parker, R., and A. Jacobson. 1990. Translation and a 42 nucleotide segment within the coding region of the mRNA encoded by the mat-α-1 gene are involved in promoting rapid mRNA decay in yeast. Proc. Natl. Acad. Sci. USA 87:2780–2784.
  • Peltz, S. W., G. Brewer, P. Bernstein, P. A. Hart, and J. Ross. 1991. Regulation of mRNA turnover in eukaryotic cells. Crit. Rev. Eukaryotic Gene Expression 1:99–126.
  • Peltz, S. W., A. H. Brown, and A. Jacobson. 1993. mRNA Destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting factor. Genes Dev. 7:1737–1754.
  • Rainier, S., L. A. Johnson, C. J. Dobry, A. J. Ping, P. E. Grundy, and A. P. Feinberg. 1993. Relaxation of imprinted genes in human cancer. Nature (London) 362:747–749.
  • Rastinejad, F., and H. M. Blau. 1993. Genetic complementation reveals a novel regulatory role for 39 untranslated regions in growth and differentiation. Cell 72:903–917.
  • Rastinejad, F., M. J. Conboy, T. A. Rando, and H. M. Blau. 1993. Tumor suppression by RNA from the 39 untranslated region of α-tropomyosin. Cell 75:1107–1117.
  • Sambrook, J., E. F. Fritsch, and T. Maniatis. 1987. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  • Savant-Bhonsale, S., and D. W. Cleveland. 1992. Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a .20S degradation complex. Genes Dev. 6:1927–1939.
  • Scheper, W. Unpublished data.
  • Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 39 untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659–667.
  • Shyu, A. B., J. G. Belasco, and M. E. Greenberg. 1991. Two distinct desta-bilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5:221–231.
  • Solnick, D. 1985. Alternative splicing caused by RNA secondary structure. Cell 43:667–676.
  • Stoeckle, M. Y. 1992. Removal of a 39 non-coding sequence is an initial step in degradation of groα mRNA and is regulated by interleukin-1. Nucleic Acids Res. 20:1123–1127.
  • Stoeckle, M. Y., and H. Hanafusa. 1989. Processing of 9E3 mRNA and regulation of its stability in normal and Rous sarcoma virus-transformed cells. Mol. Cell. Biol. 9:4738–4745.
  • Sussenbach, J. S. 1989. The gene structure of the insulin-like growth factor family. Prog. Growth Factor Res. 1:33–48.
  • Tollefsen, S. E., J. Levis Sadow, and P. Rotwein. 1989. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. Proc. Natl. Acad. Sci. USA 86:1543–1547.
  • Vakalopoulou, E., J. Schaack, and T. Shenk. 1991. A 32-kilodalton protein binds to A1U-rich domains in the 39 untranslated regions of rapidly degraded mRNAs. Mol. Cell. Biol. 11:3355–3364.
  • van Dijk, M. A., H. J. Bootsma, F. M. A. Van Schaik, P. Holthuizen, and J. S. Sussenbach. 1991. Initial characterization of the four promoters of the human insulin-like growth factor II gene. Mol. Cell. Endocrinol. 81:81–94.
  • Wisdom, R., and W. Lee. 1991. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:232–243.
  • Yen, T. J., P. S. Machlin, and D. W. Cleveland. 1988. Autoregulated instability of β-tubulin mRNAs by recognition of the nascent amino terminus of β-tubulin. Nature (London) 334:580–585.
  • You, Y., C.-Y. A. Chen, and A.-B. Shyu. 1992. U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 39 untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol. Cell. Biol. 12:2931–2940.
  • Zarrilli, R., V. Colantuoni, and C. B. Bruni. 1992. Regulation of insulin-like growth factor II gene expression in rat liver cells. Eur. J. Biochem. 209:445–452.
  • Zuker, M., and P. Stiegler. 1981. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res. 9:133–148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.